Boehringer Ingelheim Venture Fund

Suggest edits

Follow us

Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 19

Portfolio

Portfolio Tracker

Add info

$29,000,000 Venture capital (Series A)

Libra Therapeutics Raises $29M in Series A Funding

$11,200,000 Venture capital (Series A)

Bodyport Raises $11.2M in Series A Funding

€34,000,000 Venture capital (Series B)

eTheRNA Raises €34M in Series B Financing

$4,500,000 Seed fund

DiogenX Raises €4.5M in Seed Financing

€11,000,000 Venture capital (Series B)

HepaRegeniX Closes Over €11M Series B Financing round

$22,000,000 Venture capital (Series C)

NBE-Therapeutics Completes USD22M Series C Financing Round

$30,000,000 Venture capital (Series B)

Eyevensys Raises $30M in Series B Financing

Hookipa Pharma debuts IPO

€21,000,000 Venture capital (Series A)

Belgian biotherapeutics firm AgomAB inks Series A funding

$37,400,000 Venture capital (Series D)

Hookipa Pharma Raises $37.4M in Series D Financing

€10,000,000 Venture capital (Series B)

Acousia Therapeutics raises 10 mln euros

Funding Health Science

Acousia Therapeutics Raises Close to €10M in Series B Funding

Funding

€9,300,000 Debt financing

Promethera Biosciences Raises Additional €9.3M in Funding

Health Science

€15,200,000 Venture capital (Series A)

| Belgian biotech company Rewind Therapeutics picks up Series A funding

$59,600,000 Venture capital (Series C)

| Hookipa Biotech scores $59.6 mln Series C

Merck to buy VC-backed Rigontec

Health Funding

€9,000,000 Venture capital (Series A)

HepaRegeniX Raises €9M in Series A Financing

€10,000,000 Venture capital (Series C)

Venture capital (Series C)

STAT-Diagnostica Receives Investment from Siemens Venture Capital

Funding Health

€9,000,000 Venture capital (Series A)

Eyevensys Raises €9M in Series A Funding

Health

Index

By TNW